Takeda Oncology
@TakedaOncology
Official Twitter handle of Takeda’s Oncology Business. We aspire to cure cancer, with inspiration from patients & innovation from everywhere. Guidelines below:
ID:321974233
https://www.takedaoncology.com/social-media-policy/ 22-06-2011 12:50:11
9,8K Tweets
21,6K Followers
1,3K Following
This #LungCancer AwarenessMonth , we gathered in Cambridge, MA for a white ribbon making event featuring the White Ribbon Project. Attendees heard from Dave Bjork of The White Ribbon Project™ and helped assemble white ribbons to drive awareness and change perceptions of #LungCancer . #LCAM
This #KNOWvember , along with LUNGevity Foundation, we want to encourage all lung cancer patients to be fully informed about biomarker testing. Learn more about how to #KnowYourBiomarker for #NSCLC at noonemissed.org #IYKYK #LCAM #NoOneMissed
Join us at the Economist Impact events #WorldCancerSeriesEurope , where our own Philippe Jacquot, VP & Country Manager, Oncology, and Stefanie Granado, Head of Oncology, EUCAN, will be participating in discussions on real-world data and digital transformation in #oncology .
SPONSORED CONTENT: Family Reach’s Family ReachCEO speaks to Takeda Oncology’s Dion Warren about the financial impacts of cancer treatment on families, how she started working to address them, & how to get involved.
Watch this #PeopleVCancer Underwriter Session produced by Takeda
Earlier today, our own Dion Warren conducted a fireside chat with Carla Tardif, @FamilyReach CEO, at the AtlanticLIVE's #PeoplevCancer on financial toxicity. They discussed the financial costs associated with #cancer and how we're working to lessen the burden for patients.
Life-changing treatments cannot make a difference if they do not reach those who need them. Liz Lewis, Head, Global Patient Value, Policy and Access, shares her thoughts on how to #CloseTheCareGap in cancer care. #HealthEquity #ISPOREurope
Non-small cell lung cancer ( #NSCLC ) is the most common type of #LungCancer , accounting for 85% of lung cancer diagnoses. This #LungCancer AwarenessMonth, learn how identifying NSCLC mutations can help physicians pinpoint the most effective treatments for patients. #lcsm #LCAM
Join our own Dion Warren, Head, U.S. Oncology Business Unit, in a fireside chat with @FamilyReach's Carla Tardif at AtlanticLIVE's #PeopleVCancer next week to learn more about financial toxicity, a debilitating side effect of cancer.
Focusing on increasing diversity and reducing disparities in #ClinicalTrials is key to improving patient outcomes. Hear more from Liz Lewis, Head, Global Patient Value, Policy and Access. #HealthEquity
We’re proud to be a National Sponsor of The Leukemia & Lymphoma Society’s Light The Night Walk to bring light to the darkness of #cancer . Last week, we raised awareness and funds for those affected by blood cancer and support life-saving cancer research, gathering at the Boston Common to #LightTheNight .
Access to and awareness of patient resources are critical in closing the #cancer care gap. Please join us ahead of #LCAM and #LCS_Day2022 in raising awareness of the lifesaving impact of #LungCancer screening. Find a screening center near you: bit.ly/3VOjrgy #lcsm
Frank Campana, MD, Executive Medical Director, Clinical Science recently joined the The Galien Foundation's Best Rare / Orphan Drug webinar to speak about our innovation story around Hodgkin lymphoma. Watch the webinar: